Keith M. Drake

Latest Institution: Greylock McKinnon Associates

All Institutions: Harvard Medical School; Greylock McKinnon Associates

Causal Claims Network Graph

Edges that are evidenced by causal inference methods are in orange, and the rest are in light blue.

Based on the Following Papers:

Do Reverse Payment Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?

Year: 2014
Journal: International Journal of the Economics of Business
Authors: Keith M. Drake; Martha A. Starr; Thomas McGuire

No Free Launch: At-Risk Entry by Generic Drug Firms

Year: 2021
Journal: International Journal of the Economics of Business
Authors: Keith M. Drake; Robert He; Thomas McGuire; Alice K. Ndikumana

Most-Favored Entry Clauses in Drug Patent Litigation Settlements as a Potential Reverse Payment

Year: 2022
Journal: No Journal Matched
Authors: Keith M. Drake; Thomas McGuire

The Simple Math of Royalties and Drug Competition During the 180-Day Generic Exclusivity Period

Year: 2023
Journal: No Journal Matched
Authors: Keith M. Drake; Thomas McGuire

Author Disambiguation

This page includes results for all related names (only one name shown, no other authors with similar names):

Back to index